Finance

Beta
Mga Listahan
Mga sektor ng equity
Mga Simbolo
Mga Simbolo
Presyo
Palitan
% ng Pagbabago
Trend
Nakaraang Pagsara
Buksan
Mataas
Mababa
Dami
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.89%
1,083.04
-9.76
-0.89%
—1,092.801,093.681,094.851,081.97——
SIXC
Communications
SIXC
Communications
SIXC
-0.39%
602.38
-2.36
-0.39%
—604.74604.74605.10601.34——
SIXE
Energy
SIXE
Energy
SIXE
+2.31%
1,242.83
+28.03
+2.31%
—1,214.801,220.811,243.821,220.81——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.62%
1,713.82
-10.75
-0.62%
—1,724.571,727.021,732.301,707.43——
SIXM
Financials
SIXM
Financials
SIXM
+0.09%
639.99
+0.56
+0.09%
—639.43641.58644.53637.50——
SIXR
Staples
SIXR
Staples
SIXR
-0.20%
837.46
-1.69
-0.20%
—839.15836.90840.48832.89——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.65%
214.22
-1.40
-0.65%
—215.62215.62216.21213.48——
SIXT
Technology
SIXT
Technology
SIXT
+0.78%
3,204.38
+24.86
+0.78%
—3,179.523,191.503,205.093,177.75——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.23%
925.38
-11.53
-1.23%
—936.91935.42937.17923.20——
SIXV
Health care
SIXV
Health care
SIXV
-0.69%
1,442.71
-10.06
-0.69%
—1,452.771,445.931,447.431,434.91——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.16%
2,361.34
-3.84
-0.16%
—2,365.182,353.642,368.102,347.80——
RDY:NYSE
Dr Reddy's Laboratories Ltd
$13.73
-2.14%
(-0.30) 1D
$13.73
0.00% (0.00)
Pagkalipas ng oras ng trabaho
Sarado: Abr 29, 4:00:03 PM GMT-4  ·   USD
Lahat ng simbolo
SimboloPresyoPalitan% ng Pagbabago
Bumubuo ng mga nangungunang insight para sa RDY...
Buksan
$13.84
Mataas
$13.95
Mababa
$13.68
Mkt. cap
11.72B
Avg. na dami
2.32M
Dami
92.00
Dividend
0.67%
Bawat tatlong buwang dividend
$0.02
Petsa ng ex dividend
Hul 16, 2024
P/E ratio
19.12
Mataas nang 52-wk
$16.17
Mababa nang 52-wk
$12.77
EPS
$0.72
Beta
0.37
Mga natitirang share
834.62M
Bilang ng mga empleyado
28K
Mga balita at kwento
Mula sa mga source sa buong web
Profile
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr. Wikipedia
Tungkol sa Dr Reddy's Laboratories Ltd
CEOErez Israeli
Mga Empleyado27.8K
Itinatag1984
HeadquartersHyderabad, Andhra Pradesh, India
Sektor-
Websitedrreddys.com
Huling ulat
Ene 21, 2026
Fiscal Period
Q3 2026
Na-normalize na EPS / Pagtataya
14.77/ (14.27 tinataya)INR
+3.51%lumampas
Kita / Pagtataya
87.27B/ (84.52B tinataya)INR
+3.25%lumampas
Earnings call para sa Fiscal Q3 2026
Hinihintay ang earnings call
Sa isang sulyapMga insight mula sa mga pinakabagong balita at ulat
Mga nakaraang ulatLahat ng value sa INR
Loading Previous Earnings...
Statement ng kita
Kita
Net na kita
Lahat ng value sa INR
Mar 2025
Hun 2025
Set 2025
Dis 2025
Kita
85.06B
85.45B
88.05B
87.27B
Gastusin sa mga naibentang produkto
37.80B
36.82B
39.91B
40.46B
Halaga ng kita
37.80B
36.82B
39.91B
40.46B
Mga gastos sa pananaliksik at pag-develop
7.26B
6.24B
6.20B
6.15B
Kabuuang gastos sa pananaliksik at pag-develop
-
-
-
-
Mga gastos sa pagbebenta, pangkalahatan, at admin
24.06B
25.65B
26.44B
26.92B
Gastos sa pagpapatakbo
29.92B
31.11B
31.90B
32.48B
Kabuuang gastos sa pagpapatakbo
67.71B
67.94B
71.81B
72.94B
Kita sa pagpapatakbo
17.35B
17.52B
16.24B
14.33B
Iba pang hindi kita sa pagpapatakbo
719.00M
-
1.28B
570.00M
EBT na may mga hindi karaniwang item
20.05B
19.05B
18.35B
15.43B
EBT na hindi kasama ang mga hindi karaniwang item
19.76B
18.36B
17.81B
15.52B
Gastos sa buwis sa kita
4.18B
4.95B
4.08B
3.53B
Epektibong rate ng buwis
20.85%
25.99%
22.24%
22.90%
Iba pang gastos sa pagpapatakbo
-1.40B
-779.00M
-740.00M
-591.00M
Net na kita
15.94B
14.18B
14.37B
12.10B
Margin ng kabuuang kita
18.74%
16.59%
16.32%
13.86%
Kita bawat share
19.84
17.02
17.87
14.77
Kita sa interes at investment
564.00M
1.13B
912.00M
796.00M
Gastos sa interes
-656.00M
-830.00M
-907.00M
-944.00M
Mga net na gastos sa interes
-92.00M
298.00M
5.00M
-148.00M
Mga singil sa depreciation at amortization
-
-
-
-
EBITDA
20.65B
22.28B
21.29B
19.54B
Kita o pagkalugi mula sa pagbebenta ng mga asset
-1.07B
40.00M
-308.00M
-179.00M
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa
TulongMagpadala ng feedbackPrivacyMga TuntuninDisclaimer

Pananaliksik

Mga gawain ko
Wala ka pang nagagawang gawain
Lalabas dito ang iyong mga gawain. Mag-iskedyul ng mga gawain at gamitin ang Google Finance habang wala ka.
Mga Template
Briefing ng watchlist
Pang-araw-araw na pagsusuri sa iyong watchlist bago magbukas ang market
Mga Paparating na Kita
Mga paparating na ulat ng mga kita sa linggo
Abnormal na Volatility at Dami
Maagang babala sa volatility at dami ngayong araw
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa
TulongMagpadala ng feedbackPrivacyMga TuntuninDisclaimer